nonpcrbas
target
amplif
technolog
includ
transcriptionmedi
amplif
tma
nucleic
acid
sequencebas
amplif
nasba
strand
displac
amplif
sda
current
basi
broad
rang
clinic
infectiousdiseas
molecular
diagnost
amplif
technolog
sensit
specif
use
combin
tradit
endpoint
realtim
detect
format
sever
nucleic
acid
target
tma
nasba
sda
certain
advantag
pcrbase
applic
twopart
articl
review
molecular
basi
technolog
technolog
appli
clinic
diagnost
system
articl
describ
current
test
platform
avail
us
food
drug
administr
fda
nonfdaapprov
assay
avail
analytespecif
reagent
addit
openplatform
system
describ
util
standard
reagent
method
allow
user
develop
inhous
protocol
final
applic
futur
discuss
microbiolog
newslett
see
frontmatt
past
year
nucleic
acid
amplif
test
naat
move
research
set
routin
clinic
laboratori
use
molecularbas
test
wide
accept
recogn
new
gold
standard
diagnosi
mani
infecti
agent
naat
highli
sensit
specif
rapid
tradit
microbi
cultur
molecular
technolog
enabl
laboratori
identifi
infecti
agent
may
consid
origin
diagnos
confirm
clinic
diagnos
previous
would
imposs
difficult
make
eg
herp
simplex
viru
enceph
aid
discoveri
new
infecti
agent
recent
identifi
human
metapneumoviru
assay
particularli
use
infecti
agent
cultur
eg
hepat
c
viru
difficult
cultur
eg
mycobacterium
lepra
safeti
reason
laboratori
would
want
cultur
eg
variola
viru
sarsrel
coronaviru
rapid
diagnost
greatli
impact
patient
care
direct
use
appropri
antimicrobi
therapi
reduc
hospit
overal
medic
cost
enhanc
detect
infecti
agent
achiev
either
amplifi
signal
use
detect
target
nucleic
acid
directli
amplifi
target
nucleic
acid
follow
probebas
detect
exampl
signal
amplif
method
use
infectiousdiseas
diagnost
branch
dna
bdna
bayer
diagnost
tarrytown
ny
ligas
chain
reaction
lcr
abbott
laboratori
abbott
park
il
signalmedi
amplif
rna
technolog
smart
cytocel
technolog
ltd
cambridg
uk
ramif
amplif
ram
invad
assay
third
wave
technolog
madison
wi
gener
process
nucleic
acid
target
amplif
associ
pcr
excel
method
wide
use
amplif
technolog
howev
nonpcrbas
target
amplif
technolog
includ
nucleic
acid
sequencebas
amplif
nasba
transcriptionmedi
amplif
tma
strand
displac
amplif
sda
use
success
varieti
commerci
assay
detect
infecti
agent
nonpcr
target
amplif
assay
gener
offer
sensit
specif
equal
pcr
case
advantag
certain
applic
pcr
applic
adapt
nucleic
acid
target
dna
rna
mrna
rrna
multiplex
capabl
qualit
quantit
product
amplif
reaction
singlestrand
nucleic
acid
requir
denatur
prior
hybrid
tradit
probe
endpoint
detect
fluoresc
probe
use
realtim
detect
procedur
amplif
reaction
isotherm
perform
heat
block
water
bath
incubatorfluoromet
thu
greatli
reduc
equip
cost
compar
realtim
multidy
pcr
thermocycl
articl
focu
nasba
tma
sda
nonpcrbas
target
amplif
technolog
current
applic
use
clinic
infecti
diseas
diagnost
nasba
isotherm
amplif
method
achiev
coordin
activ
three
enzym
avian
myeloblastosi
viru
revers
transcriptas
amvrt
rnase
h
rna
polymeras
two
dna
oligonucleotid
primer
specif
target
sequenc
interest
fig
amplif
base
primer
extens
rna
transcript
phase
target
serv
templat
extens
primer
contain
rna
polymeras
promot
site
amvrt
form
rnadna
duplex
extens
follow
degrad
templat
rna
rnase
h
result
singlestrand
dna
contain
promot
sequenc
extens
primer
amvrt
result
synthesi
second
strand
dna
format
doublestrand
rna
polymeras
promot
rna
synthesi
polymeras
follow
rna
transcript
system
enter
isotherm
cyclic
phase
ii
result
accumul
larg
amount
singlestrand
rna
antisens
complementari
origin
target
rna
singlestrand
rna
detect
use
tradit
method
electrochemiluminesc
ecl
real
time
use
fluoresc
probe
molecular
beacon
assay
also
adapt
dna
target
nuclisen
technolog
durham
nc
compris
four
major
procedur
compon
nucleic
acid
releas
nucleic
acid
extract
nasba
amplif
target
detect
follow
procedur
boom
et
al
use
nuclisen
isol
reagent
total
nucleic
acid
purifi
varieti
sampl
type
includ
whole
blood
dri
blood
spot
blood
film
slide
plasma
serum
tissu
peripher
blood
mononuclear
cell
bodi
fluid
stool
respiratori
sampl
cerebrospin
fluid
csf
sampl
volum
rang
ml
ad
nuclisen
lysi
buffer
contain
guanidin
thiocyan
triton
viral
particl
bacteri
particl
cell
disintegr
nucleic
acid
releas
rnase
dnase
present
sampl
inactiv
silicon
dioxid
particl
ad
lyse
sampl
high
salt
condit
particl
act
solid
phase
captur
nucleic
acid
particl
wash
sever
time
remov
protein
inhibitor
final
highli
purifi
concentr
nucleic
acid
elut
silica
particl
rnase
dnasefre
water
extract
perform
manual
autom
semiautom
extract
system
see
autom
nuclisen
assay
nasba
amplif
perform
use
primer
specif
target
interest
assay
multiplex
includ
one
target
intern
control
monitor
entir
process
nucleic
acid
extract
detect
detect
rna
product
achiev
use
two
differ
format
either
endpoint
ecl
detect
real
time
use
molecularbeacon
technolog
ecl
detect
fig
aliquot
dilut
amplicon
ad
hybrid
solut
contain
streptavidin
paramagnet
bead
bound
targetspecif
oligonucleotid
function
solid
phase
captur
amplifi
target
also
includ
hybrid
reaction
mixtur
ruthenium
ru
label
detect
probe
ru
probe
either
target
specif
eg
nuclisen
qt
assay
gener
suppli
nuclisen
basic
kit
detect
modul
gener
ru
probe
use
amplif
primer
design
contain
sequenc
complementari
sequenc
gener
ru
probe
result
amplicon
detect
use
targetspecif
beadoligonucleotid
ru
detect
probe
fig
ecl
hybrid
perform
follow
ecl
detect
use
nasba
qr
reader
altern
assay
adapt
realtim
format
use
molecularbeacon
technolog
molecular
beacon
fig
hairpin
structur
consist
singlestrand
loop
sequenc
complementari
target
short
stem
fluorophor
eg
rhodamin
fluorescein
attach
end
quencher
dabcyl
attach
end
beacon
sequenc
nativ
state
beacon
close
structur
held
togeth
complementari
stem
sequenc
sinc
fluorophor
quencher
close
proxim
littl
fluoresc
light
emit
presenc
complementari
target
sequenc
beacon
bind
target
undergo
structur
chang
therebi
separ
fluorophor
quencher
light
emit
measur
specif
uv
wavelength
target
internalcontrol
molecular
beacon
specif
fluorophor
ad
start
amplif
reaction
target
amplif
continu
monitor
emit
fluoresc
molecular
beacon
probe
perform
simultan
use
nuclisen
easyq
analyz
boxtel
netherland
commerci
avail
fdaapprov
complet
kit
use
ecl
detect
includ
nuclisen
qt
assay
nuclisen
cmv
assay
new
nuclisen
easyq
assay
use
molecularbeacon
technolog
current
avail
addit
round
transcript
occur
result
copi
antisens
rna
templat
round
amplif
detect
use
probe
electrochemiluminesc
real
time
molecular
beacon
incorpor
amplif
reaction
shown
figur
reprint
permiss
inc
durham
nc
side
unit
state
addit
assay
nuclisen
basic
kit
reagent
use
develop
inhous
assay
use
analytespecif
reagent
asr
nuclisen
qt
assay
quantit
assay
measur
viral
load
plasma
total
plasma
nucleic
acid
three
intern
calibr
suppli
kit
known
low
medium
high
rna
concentr
coextract
fig
extract
perform
manual
autom
nuclisen
extractor
coamplif
wildtyp
patient
rna
sens
rna
intern
calibr
fig
perform
singl
tube
use
two
dna
oligonucleotid
specif
gag
region
encod
core
protein
target
sequenc
singlestrand
rna
product
readili
detect
ecl
hybrid
wildtyp
calibratorspecif
ru
label
oligonucleotid
probe
fig
amount
light
gener
ecl
unit
proport
amount
product
amplif
rna
copiesml
fig
calcul
base
rel
amount
rna
four
amplif
wild
type
patient
sampl
three
calibr
determin
origin
amount
wildtyp
rna
sampl
addit
extern
control
standard
necessari
quantit
howev
manufactur
recommend
high
posit
control
low
posit
control
neg
control
includ
first
run
kit
lot
neg
control
low
posit
control
subsequ
run
kit
verifi
product
perform
extern
control
also
use
monitor
assay
reproduc
lot
lot
run
run
technician
technician
multicent
clinic
evalu
qt
assay
determin
linear
rang
assay
rna
copiesml
cutoff
rna
copiesml
detect
rate
rna
copiesml
detect
rate
rna
copiesml
mean
reproduc
assay
dynam
rang
log
standard
deviat
specif
nuclisen
easyq
version
assay
quantit
assay
determin
viral
load
plasma
sampl
base
nasba
amplif
molecularbeacon
detect
assay
use
singl
cali
brator
rna
coextract
coamplifi
codetect
real
time
tube
wildtyp
rna
fig
amplif
detect
process
two
fluoresc
signal
curv
gener
interpret
nuclisen
director
softwar
algorithm
calcul
viral
load
patient
sampl
independ
studi
show
correl
coeffici
r
nuclisen
easyq
version
assay
compar
nuclisen
qt
assay
r
compar
roch
amplicor
monitor
ultrasensit
assay
assay
detect
group
subtyp
nuclisen
easyq
version
obtain
ce
mark
europ
ce
mark
product
manufactur
declar
product
compli
essenti
requir
relev
european
health
safeti
environment
protect
legisl
perform
level
technic
specif
must
accord
establish
sever
european
standard
agenc
nuclisen
cmv
assay
use
monitor
immunosuppress
patient
risk
cytomegaloviru
cmv
diseas
diagnosi
cmv
diseas
assess
respons
anticmv
therapi
assay
target
mrna
encod
phosphoryl
matrix
tegument
protein
transcrib
u
l
gene
mrna
one
abund
late
gene
transcript
detect
viral
replic
presenc
transcript
therefor
indic
activ
cmv
infect
detect
latent
infect
studi
demonstr
cmv
late
gene
transcript
altern
target
determin
activ
cmv
infect
renal
allograft
recipi
heart
lung
bone
marrow
transplant
recipi
nucleic
acid
plasma
intern
control
coextract
coamplifi
nasba
follow
ecl
detect
lower
limit
detect
assay
less
mrna
copi
multicent
clinic
trial
studi
demonstr
concord
assay
current
refer
test
includ
cell
fluoresc
signal
cultur
cmv
antigenemia
assay
activ
cmv
diseas
present
although
fda
approv
test
csf
studi
laboratori
demonstr
detect
mrna
csf
better
predictor
activ
cmvrelat
central
nervou
system
diseas
detect
cmv
dna
pcr
nuclisen
basic
kit
reagent
use
numer
investig
develop
assay
current
applic
valid
target
bacteria
virus
mycobacteria
fungi
parasit
chemokin
cytokin
genet
marker
nuclisen
basic
kit
permit
standard
assay
one
easi
format
nuclisen
kit
compon
includ
four
separ
modul
stage
analysi
sampl
lysi
nucleic
acid
isol
amplif
detect
detect
perform
use
ecl
gener
ru
probe
suppli
basic
kit
real
time
ad
targetspecif
molecular
beacon
amplif
reaction
user
design
primer
captur
probe
ecl
detect
molecular
beacon
current
one
asr
use
nasba
molecular
beacon
avail
detect
enteroviru
csf
assay
target
noncod
region
enterovir
genom
broad
reactiv
detect
echovirus
coxsackievirus
number
enterovirus
polioviru
crossreact
numer
virus
test
assay
intern
control
monitor
effici
entir
process
isol
detect
studi
laboratori
shown
rate
amplif
inhibit
less
inhibit
sampl
grossli
bloodi
sensit
assay
approxim
rna
copi
per
amplif
reaction
enteroviru
nasba
assay
detect
posit
csf
sampl
routin
viral
cultur
rapid
diagnosi
enterovir
infect
significantli
reduc
length
hospit
stay
reduc
overal
medic
cost
combin
differ
detect
format
nasba
effect
method
avail
target
sequenc
alway
detect
molecular
beacon
atrich
sequenc
nasba
assay
develop
laboratori
detect
malaria
parasit
combin
use
molecular
beacon
gener
screen
assay
ecl
detect
speci
identif
posit
sampl
wholeblood
sampl
dri
blood
spot
scrape
stain
blood
film
slide
screen
use
primer
molecular
beacon
gener
four
plasmodium
speci
assay
detect
four
speci
compar
sensit
parasitesreact
littl
min
amplicon
posit
sampl
hybrid
speciesspecif
captur
probe
gener
ru
probe
follow
ecl
detect
assay
sensit
compar
tradit
microscopi
nasba
assay
specif
microscopi
particularli
slide
difficult
interpret
low
level
parasitemia
present
assay
superior
microscopi
detect
mix
infect
nucleic
acid
extract
varieti
sampl
type
perform
manual
autom
nuclisen
extractor
reagent
use
extractor
system
ident
use
manual
nuclisen
isol
procedur
lysi
buffer
contain
patient
sampl
calibr
intern
control
silica
ad
extract
cartridg
place
instrument
fulli
autom
wash
cycl
nucleic
acid
elut
take
place
close
dispos
filter
cartridg
guarante
complet
contamin
control
nucleic
acid
extract
process
extractor
process
sampl
approxim
min
routin
molecular
diagnost
laboratori
blood
bank
test
laboratori
demonstr
excel
perform
isol
nucleic
acid
plasma
serum
use
nuclisen
rna
assay
assay
detect
bloodborn
virus
hepat
virus
altern
extract
perform
use
magnet
silica
particl
minimag
semiautom
extract
system
fulli
autom
version
magextractor
current
develop
nuclisen
easyq
system
consist
incub
analyz
comput
director
softwar
compact
incub
perform
short
preamplif
step
analyz
read
fluoresc
reaction
strip
temperaturecontrol
environ
sampl
run
less
h
assayspecif
softwar
enabl
realtim
monitor
individu
sampl
amplif
autom
data
analysi
report
quantit
qualit
result
tma
autocatalyt
isotherm
amplif
technolog
fig
util
two
enzym
rt
rna
polymeras
two
primer
complementari
target
sequenc
one
primer
contain
promot
sequenc
rna
polymeras
promot
primer
bind
target
sequenc
rt
creat
dna
copi
target
strand
extens
end
promot
primer
result
rnadna
hybrid
rnase
h
activ
rt
degrad
rna
rnadna
hybrid
result
singlestrand
dna
contain
rna
polymeras
promot
sequenc
second
primer
bind
dna
copi
new
dna
strand
synthes
rt
result
doublestrand
dna
copi
contain
polymeras
promot
sequenc
polymeras
bind
promot
sequenc
initi
transcript
dna
templat
result
mani
copi
rna
per
dna
templat
newli
synthes
rna
copi
enter
amplif
cycl
serv
templat
tma
process
exponenti
expans
rna
result
product
billion
amplicon
within
min
rna
amplicon
detect
use
varieti
technolog
describ
next
issu
cmn
vol
